Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-049999

Interim CEO & General Counsel bought 25,000 shares at $1.69 ($42,250)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2025-05-14 Purchase +25,000 $1.69 $42,250 374,646 D
Open-market purchases · 25,000 sh · avg $1.69 · $42,250
Loading xslF345X05/tm2515393-1_4seq1.xml…